ANIK vs NDAQ · rev $62.2M vs P/E 41, rev $2.53B
Anika Therapeutics Inc (ANIK) versus Nasdaq Inc (NDAQ) — a side-by-side from cached financials, not a winner call.
Anika Therapeutics Inc (ANIK) is a drug manufacturers - specialty & generic company listed on US.
Nasdaq Inc (NDAQ) is a financial data & stock exchanges company listed on US.
Latest reported ANIK revenue for 2026-06-30 was $62.2M. Net income was -$1.7M. ANIK currently screens at market cap $161.3M.
Latest reported NDAQ revenue for 2026-06-30 was $2.53B. Net income was $507.0M. Revenue was up 18.5% from 2026-03-31 to 2026-06-30. NDAQ currently screens at market cap $51.71B and trailing P/E 40.8.
ANIK currently screens at market cap $161.3M. NDAQ currently screens at market cap $51.71B and trailing P/E 40.8.
Not investment advice. Open the ANIK and NDAQ stock pages for the full models.
Not investment advice.